Innovation1 Biotech Inc.
IVBT · OTC
2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 50% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Income | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 192% | – |
| Other Income/Exp. Net | -$0 | -$0 | -$5 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$4 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$4 | -$0 |
| % Margin | – | – | -4,247.1% | – |
| EPS | -0.023 | -0.023 | -0.23 | -0.03 |
| % Growth | -1.3% | 90% | -666.7% | – |
| EPS Diluted | -0.023 | -0.023 | -0.23 | -0.03 |
| Weighted Avg Shares Out | 22 | 21 | 20 | 20 |
| Weighted Avg Shares Out Dil | 22 | 21 | 20 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$4 | -$0 |
| % Margin | – | – | -4,136.5% | – |